Weiling Xu

4.5k citations

61 papers · 3.2k indexed · h-index 30

Pulmonary and Respiratory Medicine top 1%
- Pulmonary Hypertension Research and Treatments 16
- Neonatal Respiratory Health Research 5
Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
Physiology top 2%
- Asthma and respiratory diseases 13
- Nitric Oxide and Endothelin Effects 10
Biochemistry top 2%
Cardiology and Cardiovascular Medicine top 5%
Hematology
- Multiple Myeloma Research and Treatments 5
Molecular Biology
- Protein Degradation and Inhibitors 5

Co-authors: Serpil C. Erzurum Suzy Comhair Allison J. Janocha Kewal Asosingh Raed A. Dweik Rubin M. Tuder Fares A. Masri Shuo Zheng
Cited by: Pulmonary and Respiratory Medicine Cancer Research Physiology
Journals: American Journal of Physiology-Lung Cellular and Molecular Physiology (5 papers)Scientific Reports (3 papers)American Journal Of Pathology (3 papers)
Partner nations: United States China Netherlands

In The Last Decade

Weiling Xu

58 papers receiving 3.2k citations

Peers

Countries citing papers authored by Weiling Xu

Since Specialization

Citations

This map shows the geographic impact of Weiling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling Xu more than expected).

Fields of papers citing papers by Weiling Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling Xu. The network helps show where Weiling Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weiling Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiling Xu Line = papers co-authored together Weiling Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study Hematological Oncology ·Siti Nurul Fitriah Muhamad,Chengxuan Zhang,Gahima Egide Karuranga,Jutta U. Kern,Weiling Xu,Malak M. Tfaily,Yiwen Bu,Min Zeng,Xiaowei Nie,Yuan Feng,恵介阿部,Zhongjun Xia,Yang Liang,Fengyan Jin,Hua Wang	2025	0
2	Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis Clinical Medicine ·Weiling Xu,Xinyue Liang,Shanshan Liu,秦翠平,Tingyu Sheng,William Kimberly,Yingjie Zhang,Chengxuan Zhang,Sari Maril,Euis Sartika,Nan Zhang,樹里松下,Xiaoxiao Sun,Rui Hu,Ilaria Angeletti,F. B. Dahle,Leihui Ma,L. Harrington,Yun Dai,Fengyan Jin	2024	0
3	The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study BMC Cancer ·Siti Nurul Fitriah Muhamad,Chengxuan Zhang,Jutta U. Kern,Weiling Xu,Qiao-Li Wang,Malak M. Tfaily,Min Zeng,Xiaowei Nie,Yuan Feng,Xiaoqin Chen,José Enrique de la Puerta,Yang Liang,Fengyan Jin,Hua Wang	2024	0
4	Method for depletion of mitochondria DNA in human bronchial epithelial cells MethodsX ·Michael Novotny,Weiling Xu,Anny Mulya,Allison J. Janocha,Serpil C. Erzurum	2023	1
5	Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma American Journal of Hematology ·C.P. Peters,Glennys Moore,Xinyue Liang,Weiling Xu,Alexandra Jabs,Wenyang Huang,秦翠平,田浦武雄,Tingyu Sheng,William Kimberly,Mengyao Li,Yingjie Zhang,Mengxue Zhang,Chengxuan Zhang,Jacob J. W. van de Kerkhof,Shaji Kumar,Shu Hong Song,Yun Dai,Fengyan Jin	2022	8
6	Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome BMC Gastroenterology ·Xiaojuan Zou,Zhongqi Fan,Viviana Lenis-Ballesteros,Weiling Xu,Jin Zhang,Zhenyu Jiang	2021	1
7	A novel method for pulmonary research: Assessment of bioenergetic function at the air–liquid interface Redox Biology ·Weiling Xu,Allison J. Janocha,Novi Nurmia Sari,Ryan Klatte,Franziskus Horn,Lori Mavrakis,Suzy Comhair,Mark Lauer,Calvin U. Cotton,Serpil C. Erzurum	2014	36
8	Disulfide Bond As a Switch for Copper-Zinc Superoxide Dismutase Activity in Asthma Antioxidants and Redox Signaling ·Sudakshina Ghosh,Belinda Willard,Suzy Comhair,Patricia M. DiBello,Weiling Xu,Sruti Shiva,Kulwant S. Aulak,Michael Kinter,Serpil C. Erzurum	2012	29
9	Human Primary Lung Endothelial Cells in Culture American Journal of Respiratory Cell and Molecular Biology ·Suzy Comhair,Weiling Xu,Lori Mavrakis,Micheala A. Aldred,Kewal Asosingh,Serpil C. Erzurum	2012	80
10	Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities Blood ·Samar Farha,Kewal Asosingh,Weiling Xu,Jacqueline Sharp,Deepa George,Suzy Comhair,Margaret Park,W.H. Wilson Tang,James E. Loyd,Karl S. Theil,Raymond Tubbs,Eric D. Hsi,Alan Lichtin,Serpil C. Erzurum	2011	107
11	Endothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary Hypertension Comprehensive physiology ·Weiling Xu,Serpil C. Erzurum	2011	20
12	Somatic Chromosome Abnormalities in the Lungs of Patients with Pulmonary Arterial Hypertension American Journal of Respiratory and Critical Care Medicine ·Micheala A. Aldred,Suzy Comhair,Marileila Varella‐Garcia,Kewal Asosingh,Weiling Xu,George P. Noon,Patricia A. Thistlethwaite,Rubin M. Tuder,Serpil C. Erzurum,Mark W. Geraci,Christopher D. Coldren	2010	112
13	Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension American Journal Of Pathology ·Kewal Asosingh,Micheala A. Aldred,Amit Vasanji,Judith Drazba,Jacqueline Sharp,Carol Farver,Suzy Comhair,Weiling Xu,Prabowo Nurma Arif,Lan Huang,Bela Anand‐Apte,Mervin C. Yöder,Rubin M. Tuder,Serpil C. Erzurum	2008	130
14	Alterations of cellular bioenergetics in pulmonary artery endothelial cells Proceedings of the National Academy of Sciences ·Weiling Xu,Thomas Koeck,Abigail Lara,Donald R. Neumann,Frank P. DiFilippo,Michelle Koo,Allison J. Janocha,Fares A. Masri,Alejandro C. Arroliga,Constance Jennings,Raed A. Dweik,Rubin M. Tuder,Dennis J. Stuehr,Serpil C. Erzurum	2007	316
15	Nitrotyrosine Proteome Survey in Asthma Identifies Oxidative Mechanism of Catalase Inactivation The Journal of Immunology ·Sudakshina Ghosh,Allison J. Janocha,Mark Aronica,Shadi Swaidani,Suzy Comhair,Weiling Xu,Lemin Zheng,N. S. Shekera,Michael Kinter,Stanley L. Hazen,Serpil C. Erzurum	2006	160
16	Role of epithelial nitric oxide in airway viral infection Free Radical Biology and Medicine ·Weiling Xu,Shuo Zheng,Raed A. Dweik,Serpil C. Erzurum	2006	71
17	Abnormalities in Nitric Oxide and Its Derivatives in Lung Cancer American Journal of Respiratory and Critical Care Medicine ·Fares A. Masri,Suzy Comhair,Thomas Koeck,Weiling Xu,Allison J. Janocha,Sudakshina Ghosh,Raed A. Dweik,Joseph A. Golish,Michael Kinter,Dennis J. Stuehr,Serpil C. Erzurum,Kulwant S. Aulak	2005	97
18	Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic Free Radical Biology and Medicine ·Emanuela Masini,Danièle Bani,Alfredo Vannacci,Simone Pierpaoli,Pier Francesco Mannaioni,Suzy Comhair,Weiling Xu,Carolina Muscoli,Serpil C. Erzurum,Daniela Salvemini	2005	62
19	E-cadherin expression in four kinds of carcinomas and their relations to differentiation and metastasis Chinese Journal of Cancer Research ·Y. Wang,Yiping Zhou,Weiling Xu,Lihuan Cao,Xiliang Zha	2001	3
20	Histological grading in ductal carcinomain situ of the breast Chinese Journal of Cancer Research ·Weiling Xu,Xiongzeng Zhu,Richard Rand,Xiaoyu Tu,Shun Cao	2000	2

About Weiling Xu

Weiling Xu is a scholar working on Cancer Research, Physiology, Pulmonary and Respiratory Medicine, Hematology and Biochemistry, having authored 61 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (16 papers), Asthma and respiratory diseases (13 papers), Nitric Oxide and Endothelin Effects (10 papers), Cancer-related molecular mechanisms research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Neonatal Respiratory Health Research (5 papers), Protein Degradation and Inhibitors (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (543 citations), Physiology (827 citations), Biochemistry (213 citations) and Cardiology and Cardiovascular Medicine (586 citations). Weiling Xu has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Serpil C. Erzurum, Suzy Comhair, Allison J. Janocha, Kewal Asosingh, Raed A. Dweik, Rubin M. Tuder, Fares A. Masri, Shuo Zheng, Michelle Koo and Stanley L. Hazen. Their work appears in journals such as American Journal of Physiology-Lung Cellular and Molecular Physiology, Scientific Reports, American Journal Of Pathology, Free Radical Biology and Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact